Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Endocrinology · Hyperprolactinemia

How Is High Prolactin From Psychiatric Drugs Managed?

At a Glance

High prolactin caused by a psychiatric medication should be managed with the prescribing clinician, not by stopping treatment suddenly. Options include monitoring, a supervised dose change, switching medicines, or adding aripiprazole while monitoring mental health and bone health.

First, do not stop taking your psychiatric medication cold turkey. Stopping your medication suddenly on your own can cause a dangerous relapse of your mental health symptoms [1]. If you have been diagnosed with high prolactin (hyperprolactinemia) while taking psychiatric medications, this is a known side effect—particularly for certain antipsychotic drugs [2]. There are safe, standard strategies your medical team can use to lower your prolactin levels while keeping your mental health stable [3].

Why Certain Medications Raise Prolactin

Prolactin is a hormone produced by the pituitary gland, a small, pea-sized organ at the base of your brain. Normally, the brain chemical dopamine acts as a natural brake on prolactin production [4].

Many potent antipsychotic medications (such as risperidone, paliperidone, or amisulpride) work by blocking dopamine receptors. When dopamine is blocked, the “brake” is released, and prolactin levels rise [4]. Not all psychiatric drugs do this; the risk varies significantly between different antipsychotics, and is generally much lower for antidepressants or anti-anxiety medications [2][5].

Confirming the Cause: What to Expect at Your Appointment

A single elevated blood test does not prove your medication is to blame. Prolactin levels can temporarily rise due to stress, exercise, or the time of day [6]. Before changing a medication that works for you, your doctors will want to confirm the cause.

What doctors check during evaluation:

  • Actual value and laboratory range: Checking exactly how high the level is compared to normal limits [6].
  • Repeat testing: Doing another blood test under low-stress conditions to confirm the elevation is persistent [4].
  • Other conditions: Ruling out pregnancy, an underactive thyroid (hypothyroidism), or kidney and liver issues [4].
  • Other medications: Reviewing everything you take, as other drugs can also raise prolactin [4].
  • Symptoms: Asking about irregular periods, abnormal milk production (galactorrhea), erectile or vaginal symptoms, and infertility—even if these symptoms don’t currently bother you [6][7].
  • Red flags: If your prolactin level is extremely high (often above 250 ng/mL), or if you develop new severe headaches or vision changes, this requires prompt specialist assessment and possibly an MRI to check for a pituitary tumor (prolactinoma) [4].

Standard Management Options

If your medication is confirmed as the cause, endocrinology and psychiatric guidelines typically suggest four main approaches [8][1]. The right choice depends on your symptoms, prolactin levels, mental health stability, and reproductive goals.

Management Option Potential Prolactin Benefit Psychiatric Risk & Side Effects How Follow-Up Occurs
1. Active Monitoring No change to prolactin, but avoids medication disruption No new psychiatric risks Regular blood tests and symptom checks
2. Supervised Dose Reduction May lower prolactin if current dose is higher than needed Risk of psychiatric symptoms returning Close monitoring of mental health and prolactin levels
3. Switching Medications May normalize prolactin if the new drug is “prolactin-sparing” Risk of relapse during the transition; new drug side effects Follow a specific tapering plan; frequent check-ins
4. Adding Aripiprazole Often lowers prolactin by partially activating dopamine Possible akathisia (severe restlessness), insomnia, or nausea Monitor for side effects and psychiatric changes

(Note: Adding aripiprazole for this purpose is common but may be considered “off-label” depending on your location)

Safety Warning: Watch for Psychiatric Changes
Any time your psychiatric medication is lowered, switched, or augmented with a new drug, there is a risk of your mental health symptoms returning [9]. Contact your psychiatric team promptly if you experience racing thoughts, a reduced need for sleep, unusual suspiciousness, hallucinations, or severe agitation. Seek emergency medical help immediately if you develop suicidal thoughts.

1. Active Monitoring

If your prolactin is only mildly elevated and you have no symptoms, your doctor might recommend simply watching the levels [8]. This decision requires looking at the actual lab value and considering your age, fertility goals, and long-term bone health [8][7].

2. Supervised Dose Reduction

If you are taking more medication than strictly necessary to manage your mental health, your psychiatrist might suggest a small, supervised dose reduction [1]. This requires a tailored tapering plan, as different medications must be reduced at different speeds.

3. Switching Medications

If safe for your mental health, your psychiatrist may slowly transition you to a different antipsychotic that is less likely to raise prolactin [1][3]. You must follow your doctor’s specific cross-taper plan and contact them immediately if you experience returning psychosis, mania, severe depression, or suicidal thoughts [9].

4. Adding Another Medication (Adjunctive Therapy)

If your current medication works exceptionally well and changing it is too risky, an evidence-supported option is to add a low dose of aripiprazole (an adjunctive therapy) [3]. Aripiprazole is an antipsychotic that partially activates dopamine receptors instead of fully blocking them, which helps lower prolactin [3].

In clinical studies, low doses (such as 5 mg or 10 mg) have significantly lowered prolactin for many patients [10]. However, this strategy is not for everyone. It must be carefully prescribed and monitored, as it can cause akathisia (severe internal restlessness), insomnia, nausea, or mood activation [11][12].

Why Dopamine Agonists Aren’t the First Choice

You may read about dopamine agonist medications (like cabergoline), which are standard treatments for pituitary tumors. However, they are usually not the first choice for medication-induced high prolactin [8][13].

Because these drugs strongly increase dopamine activity in the brain, they can cause psychiatric decompensation (a dangerous worsening of mental health symptoms, such as triggering psychosis or mania) [8][13]. If an MRI confirms you actually have a pituitary tumor, your endocrinologist and psychiatrist may still carefully use these medications together, weighing the risks and benefits [8]. Do not start or refuse these medications without specialist evaluation.

Long-Term Health: Bones and Hormones

Managing this condition requires teamwork between your psychiatrist and your endocrinologist or primary care provider [4].

Protecting your long-term health is critical. Long-standing high prolactin can suppress your body’s sex hormones (estrogen and testosterone) [7]. Over many years, this chronic hormone deficiency can lead to a loss of bone mineral density, increasing your risk for fractures [14]. Bone loss is not inevitable, but depending on how long your sex hormones have been low, your age, and your fracture history, your doctor might suggest a DEXA scan (a low-dose X-ray test of bone strength) to check your bone health [15].

Common questions in this guide

Should I stop my psychiatric medication if it raises my prolactin?
No. Stopping a psychiatric medication suddenly can cause a dangerous return of mental health symptoms. Contact the prescribing clinician, who can confirm the prolactin result and plan monitoring, a gradual dose change, a medication switch, or another treatment if appropriate.
How do doctors confirm that a psychiatric medication caused high prolactin?
They review the actual result and laboratory range, often repeat the test under low-stress conditions, and check for pregnancy, thyroid problems, kidney or liver problems, and other medicines. They also ask about symptoms such as menstrual changes, breast discharge, sexual problems, and infertility. A single elevated result does not prove the medication is the cause.
What treatments can lower prolactin without destabilizing my mental health?
Depending on the prolactin level, symptoms, and psychiatric history, clinicians may monitor it, lower the dose gradually, switch to a medication less likely to raise prolactin, or add low-dose aripiprazole. Each option needs a personalized plan and follow-up because medication changes can cause psychiatric symptoms to return.
What are the risks of adding aripiprazole for high prolactin?
Aripiprazole can lower prolactin when added to some antipsychotics, but it may cause severe restlessness, insomnia, nausea, or mood activation. It should be prescribed and monitored by the psychiatric team, especially for changes in mental health.
When might high prolactin require an MRI?
An MRI may be considered when prolactin is extremely high, often above 250 ng/mL, or when new severe headaches or vision changes suggest a pituitary tumor. A specialist should interpret the result and decide whether imaging is needed.
Can high prolactin affect fertility, sexual health, or bone strength?
Yes. Persistently high prolactin can reduce estrogen or testosterone, contributing to menstrual changes, sexual symptoms, infertility, and loss of bone mineral density over time. Depending on your hormone levels, age, and fracture history, your clinician may discuss a DEXA scan to assess bone strength.
Why are medicines such as cabergoline usually not the first treatment?
Medicines such as cabergoline strongly increase dopamine activity and can worsen psychosis or mania in some people with psychiatric illness. They may be considered by an endocrinologist and psychiatrist when testing confirms a pituitary tumor, but they should not be started or refused without specialist advice.

Get notified when new evidence is published on acquired hyperprolactinemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    Guidance on the treatment of antipsychotic-induced hyperprolactinemia when switching the antipsychotic is not an option.

    Rusgis MM, Alabbasi AY, Nelson LA

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2021; (78(10)):862-871 doi:10.1093/ajhp/zxab065.

    PMID: 33954421
  2. 2

    Long-term efficacy and tolerability of quetiapine in patients with schizophrenia who switched from other antipsychotics because of inadequate therapeutic response-a prospective open-label study.

    Hashimoto N, Toyomaki A, Honda M, et al.

    Annals of general psychiatry 2015; (14(1)):1 doi:10.1186/s12991-014-0039-6.

    PMID: 25632293
  3. 3

    Pharmacological treatment strategies for lowering prolactin in people with a psychotic disorder and hyperprolactinaemia: A systematic review and meta-analysis.

    Labad J, Montalvo I, González-Rodríguez A, et al.

    Schizophrenia research 2020; (222()):88-96 doi:10.1016/j.schres.2020.04.031.

    PMID: 32507371
  4. 4

    Pitfalls in the Diagnostic Evaluation of Hyperprolactinemia.

    Vilar L, Vilar CF, Lyra R, Freitas MDC

    Neuroendocrinology 2019; (109(1)):7-19 doi:10.1159/000499694.

    PMID: 30889571
  5. 5

    Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study.

    Koch MT, Carlson HE, Kazimi MM, Correll CU

    Journal of the American Academy of Child and Adolescent Psychiatry 2023; (62(9)):1021-1050 doi:10.1016/j.jaac.2023.03.007.

    PMID: 36931560
  6. 6

    Clinical Presentations of Drug-Induced Hyperprolactinaemia: A Literature Review.

    Junqueira DR, Bennett D, Huh SY, Casañas I Comabella C

    Pharmaceutical medicine 2023; (37(2)):153-166 doi:10.1007/s40290-023-00462-2.

    PMID: 36800148
  7. 7

    Overview of Hyperprolactinemia: General Approach and Reproductive Health Implications.

    Haidenberg-David F, Sidauy-Adissi J, Moscona-Nissan A, et al.

    Archives of medical research 2024; (55(8)):103102 doi:10.1016/j.arcmed.2024.103102.

    PMID: 39454469
  8. 8

    Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research.

    Grigg J, Worsley R, Thew C, et al.

    Psychopharmacology 2017; (234(22)):3279-3297 doi:10.1007/s00213-017-4730-6.

    PMID: 28889207
  9. 9

    Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychotics.

    Cai J, Li L, Shao T, et al.

    Psychiatry research 2023; (322()):115138 doi:10.1016/j.psychres.2023.115138.

    PMID: 36871411
  10. 10

    Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.

    Chen JX, Su YA, Bian QT, et al.

    Psychoneuroendocrinology 2015; (58()):130-40.

    PMID: 25981348
  11. 11

    Adjunctive aripiprazole for antipsychotic-related hyperprolactinaemia in patients with first-episode schizophrenia: a meta-analysis.

    Zheng W, Cai DB, Yang XH, et al.

    General psychiatry 2019; (32(5)):e100091 doi:10.1136/gpsych-2019-100091.

    PMID: 31673677
  12. 12

    The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation?

    Lippi M, Fanelli G, Fabbri C, et al.

    International clinical psychopharmacology 2022; (37(6)):263-275 doi:10.1097/YIC.0000000000000417.

    PMID: 35815937
  13. 13

    Management of antipsychotic-induced hyperprolactinemia.

    Tewksbury A, Olander A

    The mental health clinician 2016; (6(4)):185-190 doi:10.9740/mhc.2016.07.185.

    PMID: 29955468
  14. 14

    Relationship between antipsychotic medication, serum prolactin levels and osteoporosis/osteoporotic fractures in patients with schizophrenia: a critical literature review.

    De Hert M, Detraux J, Stubbs B

    Expert opinion on drug safety 2016; (15(6)):809-23 doi:10.1517/14740338.2016.1167873.

    PMID: 26986209
  15. 15

    Bone mineral density, prolactin, estradiol, testosterone levels and related research in male chronic patients with schizophrenia.

    Jing P, Zhang Y, Yin X, et al.

    BMC psychiatry 2026; (26(1)).

    PMID: 42436427

This page is for informational purposes only and does not constitute medical advice. Do not stop or change psychiatric medication without guidance from your psychiatrist, endocrinologist, or other clinician.